BridgeBio Pharma Inc (NASDAQ: BBIO) has seen a decline in its stock price by -9.30 in relation to its previous close of 34.21. However, the
The stock price of BridgeBio Pharma Inc (NASDAQ: BBIO) has plunged by -0.98 when compared to previous closing price of 36.67, but the company has
The stock of BridgeBio Pharma Inc (BBIO) has seen a 6.97% increase in the past week, with a 29.69% gain in the past month, and
The stock of BridgeBio Pharma Inc (BBIO) has seen a 19.95% increase in the past week, with a 16.15% gain in the past month, and
BBIO has 36-month beta value of 1.05. Analysts have mixed views on the stock, with 9 analysts rating it as a “buy,” 6 as “overweight,”
BridgeBio Pharma (NASDAQ:BBIO) and Maze Therapeutics recently announced the formation of a partnership, Contour Therapeutics, to transform and advance innovative approaches to precision medicine for
© 2024, Powered by Smart TechOne
